A Double Blind Randomized Controlled Trial of Lovaza in Adolescents With Mild to Moderately Elevated Triglycerides.
Phase of Trial: Phase II
Latest Information Update: 28 May 2013
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Hypertriglyceridaemia
- Focus Biomarker; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 03 Nov 2011 Planned End Date changed from 1 Dec 2010 to 1 Mar 2012 as reported by ClinicalTrials.gov.
- 03 Nov 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.